Furthermore, high CSF CXCL13 concentration was confirmed by several studies to be associated with an increased risk of conversion to clinically definite MS (CDMS); a higher relapse rate also accurately predicted future disease activity [171,176,177,178]. The gene discussed is CXCL13; the disease is myeloid sarcoma.